Zobrazeno 1 - 10 of 57 pro vyhledávání: '"Maggie L Dinome"'
1
Akademický článek
Microbial dysbiosis is associated with human breast cancer.
Autor: Caiyun Xuan, Jaime M Shamonki, Alice Chung, Maggie L Dinome, Maureen Chung, Peter A Sieling, Delphine J Lee
Publikováno v: PLoS ONE, Vol 9, Iss 1, p e83744 (2014)
Breast cancer affects one in eight women in their lifetime. Though diet, age and genetic predisposition are established risk factors, the majority of breast cancers have unknown etiology. The human microbiota refers to the collection of microbes inha
Externí odkaz: https://doaj.org/article/d84ba8bffe4343799788665adccf17bd
Zobrazit plný text záznamu
2
Akademický článek
Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors
Autor: Pere Llinàs-Arias, Miquel Ensenyat-Mendez, Sandra Íñiguez-Muñoz, Javier I. J. Orozco, Betsy Valdez, Matthew P. Salomon, Chikako Matsuba, Maria Solivellas-Pieras, Andrés F. Bedoya-López, Borja Sesé, Anja Mezger, Mattias Ormestad, Fernando Unzueta, Siri H. Strand, Alexander D. Boiko, E Shelley Hwang, Javier Cortés, Maggie L. DiNome, Manel Esteller, Mathieu Lupien, Diego M. Marzese
Publikováno v: Molecular Cancer, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Background Triple-negative breast cancer (TNBC) is an aggressive subtype that exhibits a high incidence of distant metastases and lacks targeted therapeutic options. Here we explored how the epigenome contributes to matrix metalloprotease (M
Externí odkaz: https://doaj.org/article/b71cb755354f404e9aa916bdd4c51c9e
Zobrazit plný text záznamu
3
Akademický článek
Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer
Autor: Miquel Ensenyat-Mendez, Javier I. J. Orozco, Pere Llinàs-Arias, Sandra Íñiguez-Muñoz, Jennifer L. Baker, Matthew P. Salomon, Mercè Martí, Maggie L. DiNome, Javier Cortés, Diego M. Marzese
Publikováno v: Communications Medicine, Vol 3, Iss 1, Pp 1-8 (2023)
Abstract Background Immune checkpoint inhibitors (ICI) improve clinical outcomes in triple-negative breast cancer (TNBC) patients. However, a subset of patients does not respond to treatment. Biomarkers that show ICI predictive potential in other sol
Externí odkaz: https://doaj.org/article/1f2057e671df4541b19b7339086d3e98
Zobrazit plný text záznamu
4
Abstract P1-06-02: The effect of race on pathologic complete response rates and overall survival in patients with triple negative breast cancer
Autor: Hannah E. Woriax, Samantha M. Thomas, Jennifer K. Plichta, Laura H. Rosenberger, Astrid Botty van de bruele, Akiko Chiba, Gayle DiLalla, Carolyn Menendez, E Shelley Hwang, Maggie L. DiNome
Publikováno v: Cancer Research. 83:P1-06
Introduction: Despite the recent overall improvement in survival for patients with breast cancer, racial disparities in outcomes persist. While studies have demonstrated that socioeconomic factors and access to treatment play a role, differences in t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09ef734d0b4eac92e930c3bf2f09ab07
https://doi.org/10.1158/1538-7445.sabcs22-p1-06-02
Zobrazit plný text záznamu
5
Akademický článek
Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
Autor: Vikram Krishna, BS, Corbin Muetterties, MD, Maggie L. DiNome, MD, Charles Y. Tseng, MD, MBA
Publikováno v: Plastic and Reconstructive Surgery, Global Open, Vol 8, Iss 9, p e3075 (2020)
Summary:. Lymphazurin 1% (isosulfan blue dye) is the most frequently used blue dye in the United States, and it is commonly used for sentinel node biopsy in breast cancer patients. Although cases of allergic reaction to lymphazurin have been reported
Externí odkaz: https://doaj.org/article/a16f039f830148b4b7716ef729831305
Zobrazit plný text záznamu
6
Abstract P3-05-20: Low 21-Gene Recurrence Score Is Not Associated with a High Axillary Nodal Burden in Post-Menopausal Women Presenting with a Clinically Negative Axilla
Autor: Astrid Botty van den Bruele, Morgan Paul, Samantha M. Thomas, Sarah L. Sammons, Maggie L. DiNome, Jennifer K. Plichta, Akiko Chiba, Laura H. Rosenberger, E Shelley Hwang
Publikováno v: Cancer Research. 83:P3-05
Background: The predictive and prognostic value of the 21-gene recurrence score (RS) has emphasized the importance of tumor biology and minimized the credence of a limited (1-3 positive) nodal burden. The practice changing results of RxPonder demonst
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::932a5c2e79798c1fe1cf7726815bb2ae
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-20
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje